局灶性结节性增生
谷氨酰胺合成酶
生物
病理
基因
基因表达
免疫组织化学
增生
癌症研究
肝细胞癌
谷氨酰胺
医学
生物化学
氨基酸
作者
Sandra Rebouissou,Gabrielle Couchy,Louis Libbrecht,Charles Balabaud,Sandrine Imbeaud,Charles Auffray,Tania Roskams,Paulette Bioulac‐Sage,Jessica Zucman‐Rossi
标识
DOI:10.1016/j.jhep.2008.03.013
摘要
Focal nodular hyperplasias (FNHs) are benign liver lesions considered to be a hyperplastic response to increased blood flow in normal liver. In contrast, FNH-like lesions/nodules occur in cirrhotic liver but share similar histopathological features. We conducted a transcriptome analysis to identify biological pathways deregulated in FNH.Gene expression profiles obtained in FNH and normal livers were compared. Differentially-expressed genes were validated using quantitative-RT-PCR in 70 benign liver tumors including FNH-like lesions.Among the deregulated genes in FNHs, 19 displayed physiological restricted distribution in the normal liver. All six perivenous genes were up-regulated in FNH, whereas 13 periportal genes were down-regulated. Almost all these genes are known to be regulated by beta-catenin. Glutamine synthetase was markedly overexpressed in anastomosed areas usually centered on visible veins. Moreover, activated hypophosphorylated beta-catenin protein accumulated in FNH in the absence of activating mutations. These results suggest the zonated activation of the beta-catenin pathway in FNH, whereas the other benign hepatocellular tumors, including FNH-like lesions, demonstrated an entirely different pattern of beta-catenin expression.In FNH, increased activation of the beta-catenin pathway was found restricted to enlarged perivenous areas. FNH-like nodules may have a different pathogenetic origin.
科研通智能强力驱动
Strongly Powered by AbleSci AI